Yoshinobu Saitoh

Yoshinobu Saitoh

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CBCostansia Bureta
Costansia Bureta
TSTakao Setoguchi
Takao Setoguchi
YSYoshinobu Saitoh
Yoshinobu Saitoh
HTHiroyuki Tominaga
Hiroyuki Tominaga
SMShingo Maeda
Shingo Maeda
NTNoboru Taniguchi
Noboru Taniguchi
The activation and proliferation of microglia is characteristic of the early stages of brain pathologies. In this study, we aimed to identify a factor that promotes microglial activation and proliferation and examined the in vitro effects on these processes. We cultured microglial cell lines, EOC 2 and SIM-A9, with various growth factors and evaluated cell proliferation, death, and viability. The results showed that only transforming growth factor beta (TGF-β) caused an increase in the in vitro proliferation of both microglial cell lines. It has been reported that colony-stimulating factor 1 promotes the proliferation of microglia, while TGF-β promotes both proliferation and inhibition of cell death of microglia. However, upon comparing the most effective doses of both (assessed from the proliferation assay), we identified no statistically significant difference between the two factors in terms of cell death; thus, both have a proliferative effect on microglial cells. In addition, a TGF-β receptor 1 inhibitor, galunisertib, caused marked inhibition of proliferation in a dose-dependent manner, indicating that inhibition of TGF-β signalling reduces the proliferation of microglia. Therefore, galunisertib may represent a promising therapeutic agent for the treatment of neurodegenerative diseases via inhibition of nerve injury-induced microglial proliferation, which may result in reduced inflammatory and neuropathic and cancer pain.

2 November 2018 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
YSYoshinobu Saitoh
Yoshinobu Saitoh
CBCostansia Bureta
Costansia Bureta
HSHiromi Sasaki
Hiromi Sasaki
SNSatoshi Nagano
Satoshi Nagano
SMShingo Maeda
Shingo Maeda
TSTakao Setoguchi
Takao Setoguchi

3 September 2019 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
HTHiroto Tokumoto
Hiroto Tokumoto
TSTakao Setoguchi
Takao Setoguchi
YSYoshinobu Saitoh
Yoshinobu Saitoh
HSHiromi Sasaki
Hiromi Sasaki
SNSatoshi Nagano
Satoshi Nagano
NTNoboru Taniguchi
Noboru Taniguchi

1 January 2018 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
CBCostansia A. Bureta
Costansia A. Bureta
MAMasahiko Abematsu
Masahiko Abematsu
HTHiroyuki Tominaga
Hiroyuki Tominaga
YSYoshinobu Saitoh
Yoshinobu Saitoh
IKIchiro Kawamura
Ichiro Kawamura
SKSetsuro Komiya
Setsuro Komiya
Introduction: Reports of hypertrophic spinal pachymeningitis associated with human T-cell lymphotrophic virus-1 (HTLV-1) infection and Sjogren's syndrome in the English literature are still very rare. Presentation of case: We hereby present a case of a 78-year-old female with a history of lower extremity weakness after a fall, which fully resolved after conservative treatment. However, the symptoms recurred 4 years later, and the patient became unable to walk. The patient had no superficial or deep sensation below the level of T9, and she also had urinary retention. Magnetic resonance imaging showed that hypertrophic dura mater was compressing the spinal cord from T2 to T10. Blood testing revealed increased anti-HTLV-1 antibody, rheumatoid factor, elevation of anti-SS-A antibody and antinuclear antibody. The cerebrospinal fluid contained markedly elevated levels of total protein and cell numbers. Biopsy of the labial gland of the lip revealed chronic sialadenitis. Discussion: In collaboration with a neurologist, we diagnosed this patient with hypertrophic spinal pachymeningitis associated with HTLV-1 infection and Sjogren's syndrome. We performed laminectomy at the affected spinal levels, resected the thickened dura, and maintained the patient on steroid therapy. The patient attained a marked recovery; she could walk with a cane and her urinary retention was improved. Conclusion: For the management of HSP associated with HTLV-1 and SS, we recommend surgical decompression with subsequent prolonged steroid therapy and prolonged close monitoring to achieve a good long-term outcome. Highlights:

3 January 2018 in Acta Orthopaedica et Traumatologica Turcica
Verified
Journal Article
Open access
YSYoshinobu Saitoh
Yoshinobu Saitoh
TSTakao Setoguchi
Takao Setoguchi
TYTakako Yoshi̇oKa
Takako Yoshi̇oKa
JNJunichiro Ni̇sHi̇
Junichiro Ni̇sHi̇
ATAkihide Tanimoto
Akihide Tanimoto
SKSetsuro Komi̇yA
Setsuro Komi̇yA
Objective The aim of this study was to evaluate whether intraoperative histopathological examination could predict the risk of relapse of infection in periprosthetic joint infections (PJI). Methods The study included 25 patients (14 women and 11 men, with a mean age of 67.0 years (range, 37–83 years)), who had two-staged revision surgery for a PJI. Following prosthetic removal in the first stage, all patient underwent an intraoperative histopathological examination during the second stage. The patients were divided into PMNs-positive group (?five PMNs per high-powered field) or -negative group (Results Intraoperative histopathological revealed that 8.0% of cases were PMNs-positive. Postoperative histopathological examination revealed that 28.0% of cases were PMNs-positive. 28.0% of cases showed discrepancy between the PMNs-positivity. Intraclass correlation coefficient indicates poor reproducibility. Infection relapse after revision surgery occurred in two cases (8.0%); both relapse cases were from the PMNs-negative group. There was no statistical relationship between the presence of PMNs in periprosthetic tissue by intraoperative or postoperative histopathological examination and relapse of infection. Conclusions Our findings showed that intraoperative histopathological examination could not predict the relapse of infection. Intraoperative histopathological examination promotes overdiagnosis of the requirement for re-implantation of antibiotic-impregnated cement and prolonged treatment periods. Level of evidence Level III, diagnostic study ER -